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ARTICLE
The role of valve stiffness in the insurgence of deep
vein thrombosis
Zoe Schofield1,2, Hosam Alden Baksamawi1, Joana Campos3, Alessio Alexiadis1, Gerard B. Nash3,
Alexander Brill 3,4,5✉ & Daniele Vigolo 1✉
Deep vein thrombosis is a life-threatening development of blood clots in deep veins.
Immobility and blood flow stagnancy are typical risk factors indicating that fluid dynamics
play an important role in the initiation of venous clots. However, the roles of physical
parameters of the valves and flow conditions in deep vein thrombosis initiation have not been
fully understood. Here, we describe a microfluidics in vitro method that enabled us to explore
the role of valve elasticity using in situ fabrication and characterisation. In our experimental
model the stiffness of each valve leaflet can be controlled independently, and various flow
conditions were tested. The resulting complex flow patterns were detected using ghost
particle velocimetry and linked to localised thrombus formation using whole blood and an
aqueous suspension of polystyrene particles. In particular, valves with leaflets of similar
stiffness had clot formation on the valve tips whereas valves with leaflets of different stiffness
had clot formation in the valve pocket.
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Deep vein thrombosis (DVT) is a disease in which bloodclots form in the deep veins usually, but not exclusively, ofthe legs. These clots can become unstable, get detached
and travel to the lungs causing a potentially fatal condition
known as pulmonary embolism (PE)1. DVT and PE, designated
together as venous thromboembolism (VTE), develop in about
900,000 Americans annually leading to high morbidity and
mortality2. Despite this, the mechanisms underlying DVT
initiation remain unclear.
It is a general assumption that DVT starts in the venous valve
sinus due to a stagnant region behind the leaflet3. In contrast to
arterial thrombosis that usually results from atherosclerotic pla-
que rupture and platelet accrual at the exposed subendothelial
matrix4, thrombosis in veins is not accompanied by endothelial
denudation5. Blood flow stagnation up to stasis is considered one
of the major factors triggering DVT6. Interrupted flow usually
results from immobilisation of the person for reasons such as
bed-ridden position after surgery, paralysis or long-haul flights.
For example, in paediatric patients, lack of movement exceeding
3 days is a recognised risk factor for venous thrombosis with each
additional day of stay at hospital increasing the probability for
DVT by 3%7. Blood flow in veins becomes slower8 and valves
stiffer with age which correlates with greatly increased prevalence
of DVT in elderly people9. Slow blood flow causes low oxygen
tension (hypoxia) in the venous wall, which initiates
inflammation-like processes leading eventually to thrombosis10.
Thus, the significance of reduction in flow as a risk factor
implies that local characteristics of flow play a leading role in
DVT pathogenesis.
In vivo models of DVT include flow restriction in a major vein
(usually the inferior vena cava, IVC) in rodents to induce
thrombus formation11–13. These models have been useful for the
development, for example, of drugs to treat DVT12,14, however,
they do not allow for exploring the importance of physical
parameters triggering thrombosis (blood flow, elasticity of the
valve, etc.). Indeed, a specific pattern of flow inside valves has
been demonstrated. Two counter-rotating vortices are formed in
the valve space contributing to the prolonged residence of blood
in the area6. In addition to blood stasis in the valve pocket, there
is mixing at the valve tips due to vortex formation. The vortex
encourages circulation of the cellular and humoral prothrombotic
factors facilitating their interaction.
Despite their role in venous thrombosis, flow patterns around
the valves have been scarcely investigated in part due to lack of an
appropriate in vitro model that would recapitulate valves in a real
vein. More recently, numerical simulations have paved the way
for valve models15–18. However, there is a distinct lack of
experimental validation.
Venous flow varies, dependent on factors, such as posture,
muscular exertion, hydration, and vessel diameter19. Moreover,
the local flow pattern is also affected by the geometry of
the valves, and their mechanical properties. Definition of the
roles of these mechanical parameters is paramount for
understanding the mechanisms of DVT initiation. Therefore,
micro-/milli-fluidics provides an ideal platform, allowing for
highly controlled environments in which the size of the
channels and the flow rates can be controlled precisely to
mimic in vivo conditions20–23. For example, in the work by
Lehmann et al.24, a series of rigid constructions mimicking a
valve are used to study flow pattern changes at a fixed
flow rate. In concert with our findings, this group observed
two vortices forming in the valvular pocket. This work also
showed the dependence of thrombus initiation on platelet
accumulation and activation. However, rigid valves and a
continuous flow may not reflect properly the sequence of
events in real veins.
Therefore, to precisely delineate the role of flow geometry in
cell accumulation we exploited microfluidics to develop our
in vitro model of a vein by creating a microchannel (typical cross
section of 300 µm by 100 µm and several centimetres long as
shown in Fig. 1a) made of polydimethylsiloxane (PDMS) using
standard soft-lithography techniques25. We then incorporated
flexible valves made of polyethylene glycol di-acrylate (PEGDA),
by in situ photo-polymerisation (see Fig. 1a, b). Finally, we
controlled the flow rate by a syringe pump (for continuous flow)
or a pressure controller (for pulsed flow). This gave us the ability
to mimic the motion of blood, both forward and backwards, in
the presence of valves and demonstrated that variation in leaflet
rigidity modified the flow patterns and induced the formation of
aggregates of synthetic particles dispersed in water and platelets
in whole blood. We thus revealed that (1) leaflet ends are primary
points of initial accumulation, (2) increase in the rigidity of
leaflets leads to higher particle accrual when rigidity of both
leaflets in a valve is the same and (3) when rigidity of leaflets in a
valve is different, particles accumulate preferably in the leaflet
pocket as a result of the asymmetrical flow. An important feature
of our model is the use of pulsatile flow, which mimics the effect
of the muscle pump, accelerating blood flow in the veins. Thus,
we demonstrate herein that changes in valve stiffness may affect
thrombus formation (although stiffness of the vessel wall itself
could not be taken into account in this model). This approach
may be useful for future studies of the physical parameters pre-
disposing to DVT initiation.
Results and discussion
Characterisation of flow pattern. In order to evaluate the
changes in flow characteristics due to the presence of flexible
valves, we used a recently developed all-optics technique, ghost
particle velocimetry (GPV)26–30. GPV uses nanoparticles and
bright field microscopy to generate a speckle pattern used to track
the flow (see Supplementary Methods; Supplementary Figs. 1–3;
Supplementary Movies 1 and 2).
Using GPV we were able to obtain detailed flow profiles.
Venous flow is highly variable hence a range of flow rates (1–900
μL/min) and elasticity of valves (Young’s modulus, E, in the range
47–100 kPa) have been explored. To maintain hydrodynamic
similarity between our in vitro and the in vivo condition we kept
the Reynolds number (Re) in a physiological range typical for
veins31,32. To model a ‘healthy’ vein, we used a flexible valve (E=
46.7 ± 5.2 kPa). This valve opens to its maximum extent at the
highest flow rate emptying the stagnant pocket behind the valve.
On the other hand, with a stiffer valve, an increased stagnant
region and, consequently, a higher residence time of fluid behind
the valve is detected. This is representative of elderly people
where the valve tissue becomes less flexible33 due to an increase of
fibrotic tissue34. In all cases we kept the stiffness of the vessel
constant to emphasise the effect due solely to the valve elasticity.
Venous flow in general is not continuous; the blood is pushed
back to the heart via muscle contractions (muscle pump) and
back flow is prevented by the presence of valves3. These
conditions were replicated using a pressure controller to pulse
the flow through the valves causing them to open and close to
better mimic the physiological conditions. In the presence of back
flow, the valve closed and the flow recirculated in the valve
pockets, encouraging vortex formation. The opening and closing
of the valve permitted partial removal of the fluid trapped in the
valve pocket proportionally to the valve stiffness.
Vortex characterisation. As the stiffness of the valve increased, a
larger space between the valve and the channel wall formed for a
vortex to occur. The flow velocity between the valve leaflets
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became increasingly higher than the velocity through the main
channel resulting in the formation of a jet responsible for the
onset of a pair of symmetrical vortices, one at each leaflet tip
(Fig. 1c and Supplementary Movie 1). These vortices increased
the residence time of the fluid at the valve tips. An extended
residence time in vivo can increase the likelihood of a thrombus
forming due to a higher chance for activated cells to collide and
form aggregates35.
In Fig. 1c, we show the velocity profile maps and streamlines
collected using GPV. It is possible to notice a vortex forming at
the valve tips at higher flow rates, identified by the Reynolds
number, Re, defined as Re ¼ ρvD=μ, where ρ is the density, v the
flow velocity, D the hydraulic diameter and µ the viscosity of the
aqueous suspension.
Next, we demonstrated how the size of the vortices depended
on the velocity of the fluid and the elasticity of the valve. Figure 2a
shows the dependence of the vortex area on the Re which
increases following a power law. Higher flow velocities contribute
to the elongation of the vortex along the channel. As a
consequence, also the circulation, defined as the integral of the
tangential velocity around the vortex, increased with Re.
Circulation varied within a vortex and reached a maximum at
the boundary. We illustrated this by showing the minimal and
maximal circulation values for each Re in Fig. 2b. Due to
confinement within the microfluidic channel, the circulation
tended to reach a plateau for high Re following a logarithmic
behaviour (Fig. 2b), while it increases linearly with the vortex area
(see Supplementary Fig. 4).
In the presence of softer valves, higher deformation occurred
that induced a reduction in vortex size (Fig. 3a). This is a
consequence of the fact that these valves opened wider at the
same flow rate compared to stiffer valves (Fig. 3b). This, in turn,
Fig. 1 Vortex formation in the presence of flexible valves. a A Schematic diagram of mask alignment through the fluorescent light of an inverted
microscope. The mask was designed in order to produce the desired valve size through a 20× objective. b Optical image of the flexible valve obtained. The
length of the valve is about 330 µm, the width of each leaflet starts at about 45 µm and it tapers towards the tip. The initial gap in between the leaflets
when there is no flow is about 30 µm. The scale bar represents 100 µm. c The top image is a velocity profile map with the site of vortex formation at the tip
of the valve designated by the dashed line. Images below (from left to right) represent the vortex getting larger with increased flow rate (valve properties:
2% w/v [PI] and 40% w/v [PEGDA]).
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generated a jet with lower flow velocity and thus a smaller vortex
characterised by a lower tangent velocity and thus lower
circulation. For the lowest flow rate used in our experiments,
the vortex did not occur (Fig. 3b and Supplementary Movie 2),
even for the highest Young’s modulus we tested. Thus,
independently from the valve stiffness, we identified a threshold
flow rate for which we did not observe the formation of vortices.
This shows a clear link between the elasticity of the valve, flow
velocity and vortex formation and identify the stiffness of the
valve as the most significant parameter affecting the range of
movements of the valve and therefore the size of the stagnant
region34,36. In particular, at low flow rate typical of DVT, the
position of the valve leaflets is solely determined by the stiffness
of the valve and its dependence on the flow rate is negligible
(Fig. 3b).
To further extend the range of Re investigated, a larger 3D
printed device was used. This allowed us to study Re up to 163
(Fig. 2a) and evaluate the flow pattern by GPV. Although typical
Re for healthy human veins can be higher32 we focused on the
conditions favouring DVT, which is characterised by low blood
flow rate or stagnation.
In vitro thrombus formation. A general assumption is that
venous thrombosis occurs in the valve pockets due to the stasis in
the valvular pockets37. Yet it remains unclear where a thrombus is
initiated. In order to investigate this experimentally we flowed an
aqueous dispersion of polystyrene (PS) particles within the
microfluidic device using either continuous or pulsed flow. PS
particles have a tendency of forming aggregates due to Van der
Waals and electrostatic interactions between themselves and solid
surfaces. In addition, we performed similar experiments using
whole blood with fluorescently labelled platelets from three dif-
ferent donors. In order to quantify the particle or platelets accrual
on the valves, the surface area of the particle build up was eval-
uated using ImageJ38 (additional details available in the Supple-
mentary Methods).
Using this approach, we studied the influence of the valve
stiffness on the formation of aggregates. A healthy valve is flexible
enough to permit an efficient exchange of blood with minimal
flow stagnation; due to diseases or age valves tend to become
stiffer. In addition, it is reasonable to speculate that the stiffness
may change to the same or different extent for each leaflet39.
Hence, we investigated particle agglomeration in valves with
leaflets of identical (symmetrical valve) or different stiffness
(asymmetrical valve).
Symmetrical valve. Firstly, we tested continuous flow conditions
with 200 nm PS particles. As we increased the flow rate, the
particles build up decreased. In a typical experiment we mon-
itored the particles accumulation by acquiring images every 100
ms for 5 min and evaluating the surface area covered by the
aggregate to capture gradual build-up of particles over time. For
Fig. 2 Vortex characteristics. a Vortex area increases as ≈Re2.7 (dashed line, R2= 0.9057). b Circulation correlates with Re; the size of the marker point
represents the minimum and maximum circulation calculated for the vortex developing at the tip of the valve and the dotted line represents a logarithmic fit
(R2= 0.9788).
A B
Fig. 3 Vortex size dependence on flow rate for three different stiffnesses of the valve. a The size of the vortex increases linearly as the flow rate and/or
the stiffness increases. The lines are linear fits. b Dependence of the degree of valve opening on flow rate for three different valve stiffnesses. Here, the
smaller the distance from the channel wall the more the valve is open. As a consequence, for more flexible valves (lower Young’s modulus) the distance
from the channel wall is smaller for a fixed flow rate compared to more rigid valve and the vortex associated is smaller (see panel a). In the plot, the grey
area represents the region where no vortices were observed, independently of the stiffness of the valve tested. The error bars represent standard error.
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example, at a flow rate of 50 μL/min, after 5 min, we detected a
large accumulation of particles occupying a surface area of 10,500
± 1300 μm2 on the valve tips, considerably larger than the accu-
mulation at a flow rate of 150 μL/min (1300 ± 250 μm2) after the
same time (a snapshot is shown in Supplementary Fig. 5). These
results are consistent with DVT cases as there is an increased
likelihood of developing DVT when immobile (long haul flights/
surgery/bed ridden).
Next, the pulsed flow was tested. We used a pressure controller
set to pulse between 0 and 100 mbar with a frequency of 1 Hz to
flow an aqueous suspension of 3 and 10 µm diameter PS particles.
These sizes were chosen as similar to platelets40 and red blood
cells41. Maximal flow velocity through the channel was 0.2 m/s.
Movement of the valves caused the particles to build up at the
tip of the leaflets, similarly to the continuous flow. By varying the
elasticity of the valve, we found a direct correlation between
stiffness and particle accumulation (Fig. 4b).
Particle build up was consistently localised at the valve tips
(Figs. 4, 5, and Supplementary Movie 3).
We then pulsed whole blood between 0 and 250 mbar,
corresponding to the same flow rate used for the aqueous
suspension of PS particles. We found that, for stiff valves
(prepared with 50% PEGDA and 4% PI, corresponding to a
Young’s modulus of about 67.8 ± 5.5 kPa), similarly to what
discovered for PS particles, platelets accumulate preferentially at
the valve tips where they form an aggregate. The adhesion of this
clot to the valve tip is not as strong as the PS particles and as a
consequence it detaches after reaching a critical size and forms
again if pulsed flow is kept (Fig. 6 and Supplementary Movie 5).
We then tested valves of lower stiffness (30% PEGDA and 4% PI,
corresponding to a Young’s modulus of about 46.5 ± 5.2 kPa)
again for the same pulsed flow conditions and found no
accumulation anywhere on the valve or on the main channel.
This confirmed that valve elasticity is crucial in modifying the
flow pattern and to inhibit particles and platelets accumulation.
Also, flexible valves react faster to the change in flow direction
and can potentially detach the platelets that temporarily
accumulate at their tips. These results imply that the mechanism
of platelets accumulation is solely dependent on the flow
conditions that develop due to a higher stiffness of the valve. In
this study, we aimed to recapitulate primarily the interaction of
the pulsatile type of flow, specific for veins, with flexible valve
leaflets, and less emphasis was made to mimic the precise flow
shear stress. In order to maintain hydrodynamic similarity (e.g.,
same Re) with different veins, the flow velocity in our
microfluidic device has been adjusted proportionally. Hydro-
dynamic similarity implies that, despite the fact that the absolute
value of the shear stress is different between our device and real
veins, its role is proportionally the same in the fluid mechanics of
the two systems. When it comes to the effect of shear on platelets
agglomeration, it is the absolute value that counts. In the
range of shear rates used in this study (<2500 s−1), platelet
aggregation predominantly occurs via GPIIbIIIa interaction with
fibrinogen, which requires activation of the integrin by soluble
agonists that were absent in our experiments42–44. Aggregation
through GPIb-von Willebrand factor (VWF) interactions, which
does not require activation of GPIb, develops in much higher
shear rates with full shift to this mechanism at shear rates above
10,000 s−1 45. We did not observe any aggregates in the same
shear conditions for a flexible valve. Altogether this suggests that
platelet agglomeration found in our experiments is likely not
induced by shear, and hydrodynamics is the main driving force
behind the observed agglomeration. At the same time, interaction
of VWF with GPIbalpha is implicated in DVT in the in vivo
stenosis model12. This may be due to local release of highly
adhesive ultra large multimers of VWF from Weibel–Palade
bodies combined with limited supply of ADAMTS13, an enzyme
that cleaves VWF, because of restricted blood flow.
Valve symmetry thus plays an important role in the formation
of the flow patterns through the channel. Due to the laminar flow
conditions combined with the identical valve’s mechanical
characteristics, two symmetrical vortices develop, one after each
valve leaflet (Supplementary Movies 1 and 3).
Asymmetrical valve. It has been reported that leaflets of the same
valve in a diseased vein may have different thickness/rigidity39.
We thus fabricated valves with one leaflet stiffer than the other
and studied how this affected particle accumulation. We noticed
that in the asymmetric case there was a significant difference in
the flow pattern and ultimately in the particle build up (Fig. 5).
In this condition, no vortex was formed after the valve as
demonstrated by our GPV analyses and the time lapse videos
recorded (Supplementary Movie 4). The asymmetry of the valve
caused the more flexible leaflet (left in Fig. 5) to move within the
pulsed flow whereas the stiffer leaflet (right in Fig. 5) remained
almost stationary resulting in an asymmetrical flow pattern after
the valve. This triggered particle accumulation in one of the valve
pockets behind the leaflet, which proceeded faster compared to
the symmetrical case (Supplementary Movie 4). When repeated
with whole blood, the experiment showed a remarkable similarity
with the results obtained for PS particles although the blood cells
aggregate formed behind the valve was considerably smaller
compared to the one made of PS particles and required a longer
time to form (see Supplementary Movie 6).
Of note, in symmetrical conditions, both forward and back
flows caused particles accumulation on the valve tips whereas in
asymmetrical valves, back flow was the main cause for particle
build up behind the valve. In both cases, increased stiffness
enhanced or triggered particle accumulation, which is consistent
with conditions leading to DVT.
In summary, we present herein an in vitro approach that
combines in situ fabrication of flexible valves with tuneable
elasticity and controlled flow in a microfluidic environment to
produce prothrombotic conditions. By exploiting this novel
approach, we were able to demonstrate how the stiffness of the
valves influences the flow pattern in a vein and how this can be
quantified by optical measurements. We then linked the flow
behaviour to the presence of stagnant regions and vortices, and
identified critical valve parameters, such as flexibility and flow
rates, responsible for the formation of aggregates.
In particular, by using aqueous suspension of PS particles and
whole blood, we showed for the first time that varying stiffness,
and in particular stiffness asymmetry between valve leaflets, leads
to different particle build up patterns. Independently of the
sample observed, localised accumulation in symmetrical valves
occurs on the valve tips and increases with increasing stiffness,
whereas asymmetrical valves showed an accumulation in the
valve pocket behind the leaflet. The asymmetry altered the flow
patterns around the valve flaps forcing particles to get trapped in
the recirculation zone behind the valve. Our system does not
include other components of Virchow triad (blood coagulation
and vascular wall alterations). This allows for more precise
delineation of the specific role of flow geometry in thrombosis
initiation but studies combining our model with other triad
components should be the next step of this line of research.
Our results are consistent with findings that the risk of DVT
increases with old age as valves become stiffer, and also suggest
that circumstances where valve symmetries are not maintained
might increase the risk of DVT.
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A
B
Fig. 4 Accumulation behaviour for valves of different stiffness. a Positive correlation between valve stiffness and size of the aggregate formed by the
accumulation of polystyrene particles of 3 µm (left, 0.1% w/v) and 10 µm (right, 1% w/v) in diameter in the case of symmetrical valve rigidity and pulsed
flow condition (0–100mbar, 1 Hz). The valves were made of 50% [PEGDA] and, 4, 6, or 8% [PI], respectively from softer to stiffer. The data were
analysed statistically using one-way ANOVA followed by Tukey post hoc test. b Typical accumulation behaviour over time for 10 µm polystyrene particles
(1% w/v) in diameter in the case of symmetrical valve rigidity and pulsed flow condition (0–100mbar, 1 Hz). The scale bars represent 100 µm.
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Fig. 5 Accumulation behaviour for symmetrical and asymmetrical valves. Time-lapse images of particles building up over time on symmetrical (top) and
asymmetrical (bottom) valves; both are 4% (w/v) PI and 50% (w/v) PEGDA but the right-hand side leaflet on the asymmetrical valve was exposed to UV
light for a longer time compared to the left-hand side leaflet (500 and 300ms, respectively) resulting in an asymmetrical stiffness. The scale bars
represent 100 µm.
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Fig. 6 Platelets accumulation for symmetrical and asymmetrical valves. a Time-lapse images of blood aggregate building up over time on stiff
symmetrical valves (see also Supplementary Movie 5). The aggregate forms rapidly within 30–40 s of pulsed flow conditions as shown by the fluorescently
labelled platelets accumulating at the tip of the leaflets. It then increases slowly until eventually it detaches (in this case after 93 s). The arrow indicates the
aggregate and the scale bar represents 100 µm. b Growth of the aggregate over time showing initial fast growth followed by a plateau and eventually
detachment (as identified by the sudden fluorescence signal decay). At its maximum size the surface coverage was about 1200 µm2 on the valve tip.
c Time-lapse images of blood aggregate building up over time on asymmetrical valves (see also Supplementary Movie 6). The aggregate forms slowly
behind one of the leaflets. The arrow indicates the aggregate and the scale bar represents 100 µm. d The size of the aggregate becomes substantial after
about 20min and keeps growing exponentially. The continuous line is an exponential growth fit. The error bars represent standard error.
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Our work shows clear evidence that physical conditions, such
as the characteristics of the flow or valves, are responsible for the
flow behaviour in the veins, which is finally connected to different
mechanisms of cell agglomeration. The entire complex of factors
affecting flow geometry, some of which cannot be changed but
can be tested in patients (e.g., flow velocity, vortices, or degree of
valve leaflet flexibility), and others can also be modified (e.g.,
blood viscosity or haematocrit) may become a basis for more
personalised prediction of DVT probability in the future.
Modification of the latter group of factors may also be included
in the complex of measures for DVT prevention.
Our in vitro model reflects the effect of physical parameters on
the formation of thrombi happening in vivo. Thrombosis will be
also influenced by biochemical aspects such as coagulation
factors, nonetheless here we show how the physics of the venous
system can represent a key that can potentially be exploited for
prediction of DVT. As a notable example, our results highlighted
how asymmetrical stiffness links to the formation of an aggregate
behind the valve leaflet (where it is normally found in in vivo
studies). This parameter has not been investigated so far and it
could be a potential indication of a higher DVT risk.
Methods
Channel fabrication. Conventional photolithography techniques were used to
fabricate microfluidic devices out of polydimethylsiloxane (PDMS) (Sylgard® 184
Silicone Elastomer Kit, Dow Corning, UK)25. Briefly: SU8-2075 photoresist
(MicroChem, Westborough, USA) was spin coated onto a silicon wafer (Si-Mat,
Germany) and it was then exposed to ultra violet light using a mask aligner
through a photo mask (Micro Lithography Services Ltd., UK). The uncured pho-
toresist was then washed away to obtain a negative replica. PDMS (10:1 w/w ratio
with curing agent) was then poured over the silicon wafer mould to create the
microfluidic channel. The typical geometry consisted in a straight channel with
dimensions: width, W, 300 μm, height, H, 80–100 μm and length, L, 2 cm. The
PDMS was degassed under vacuum before curing it in an oven at 70 °C for 2 h.
Once the PDMS was cured it was removed from the mould and used to fabricate
the microfluidic device. Inlet and outlet were punched by a biopsy puncher (1.5
mm, Miltex by Kai) to create the top layer of the microfluidic device. For the
bottom layer we used a glass slide spin coated with ≈250 μm of PDMS (30 s at 1500
rpm) and left to cure on a hot plate at 90 °C for 20 min. To assemble the device
both layers were treated with a corona discharge (PZ2 Handheld Device, Relyon
Plasma GmbH, Germany) and bonded together.
Valve fabrication. The valves were made of polyethylene glycol diacrylate
(PEGDA) (Mr ≈ 575, Sigma Aldrich, UK) and photo initiator (PI) 2-hydroxy-2-
methyl propiophenone (Sigma Aldrich, UK). The PI permit the crosslinking of
PEGDA when exposed to UV light with a wavelength, λ, of about 365 nm. First, a
solution of PEGDA and PI was injected into the channel and left to settle ensuring
that no flow was present within the device. A syringe was connected to the inlet
and outlet to apply enough pressure to remove air bubbles as well as to stabilise the
system. Once flow has settled a photo-mask with the desired geometry was placed
at the conjugated plane in the epi-fluorescence light path of an optical microscope
(Nikon Ti-U, Japan) and illuminated with an LED source containing a UV band
(SOLA-SE-365, Lumencor, USA). To help with the alignment of the projection and
channel and to prevent premature curing, a filter was used (λ= 545 ± 25 nm). The
filter was then switched to allow the selection of the UV wavelength (λ= 350 ± 50
nm) to cure the PEGDA and reproduce the desired shape. This whole process was
carried out using a 20× objective (Fig. 1a). PEGDA does not polymerise in the
presence of oxygen46. As PDMS is oxygen-permeable, a thin layer of PEGDA
(about 3–5 µm) remain liquid after UV exposure. This guarantee the possibility to
fabricate valves that can move freely but also require to anchor them to keep them
in place (Fig. 1a). The lowest exposure time required to achieve the best resolution
was adopted, in our case 300 ms.
In order to create asymmetrical valves each leaflet was fabricate separately. We
used a mask for each leaflet and controlled the characteristic of each one
independently by modifying PEGDA or PI concentration or UV exposure time.
Finally, after valve fabrication, the channel was flushed with DI water and the
whole device was submerged in water to preserve hydrophilicity until the
experiment was performed, and in any case for no more than 24 h.
In situ valve characterisation. In order to manipulate the elasticity of the valves
fabricated by in situ photo-polymerisation, we altered their composition and
exposure time to UV light. The mechanical properties are dependent on the
concentrations of PEGDA, PI, and exposure time46,47.
We characterised the elasticity of the valves by evaluating the Young’s modulus
in situ as described previously46,47. It is in fact possible to link the deformation, hx,
of the valve measured as seen in Fig. 7a, to the Young’s Modulus46,47. The results
are shown in Fig. 7d where a linear extrapolation (red dashed line) to 100% (w/v)
PEGDA gives the maximum reading of 142 kPa which is the maximum Young’s





where E is the Young’s modulus, R is the ideal gas constant, T is the temperature
and ρ is the density.
Ghost particle velocimetry. We tracked the flow exploiting GPV26–29. We used
bright field microscopy and 200 nm PS particles (0.2% w/v, Sigma Aldrich, UK) as
tracers. By reducing the numerical aperture of the condenser lens, we were able to
detect the speckle pattern generated by the light scattered by the nanoparticles
within the fluid using a fast camera (Photron, SA5). The speckle pattern is
representative of the fluid motion as the PS particles are small enough to behave as
passive tracers and the flow is considerably faster than the Brownian diffusion of
the nanoparticles26. In addition, as the speckle pattern is uniform close to the
interfaces, GPV permitted us to accurately map the flow field in the proximity of
the flexible valve.
Enhancement of the speckle pattern is carried out using imageJ38 by subtracting
the median of the total number of frames (more than 100) and thus removing the
static contribution (see Supplementary Methods)28. It is then possible to track the
Fig. 7 In situ Young’s modulus evaluation. a A schematic diagram of how the deflection, hx is measured. b The deflections measured for different flow
rates. c Zoomed in of the circled region in panel b designating the small linear deflection (first six points) which is used to calculate the Young’s modulus in
plot D. Panel b and c refer to the case of 50% PEGDA concentration. The data shown in panel d refers to a fixed concentration of PI equal to 4% (w/v). The
error bars represent standard error.
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speckle pattern using an open source MATLAB software, PIVlab48, that performs a
cross correlation between each frames pair to obtain the flow displacement over
time and permit to analyse the flow profiles including vortex detection and shear48.
We captured the speckle pattern at various frames per second, fps, in the range
125–30,000 fps, adapting it to the flow rate and size of the device. This is done by
allowing the average displacement of the flow to be less than half of the lateral size
of the region of interest considered in the cross-correlation process.
To ensure accuracy of the GPV we compared the experimental results with the
theoretical values expected as shown in the Supplementary Methods.
Blood sample preparation. Whole blood was drawn from the cubital vein of three
healthy donors for each series of experiments performed. The study conforms with
principles outlined in the Declaration of Helsinki and informed consent was
obtained from all donors. Blood was drawn from the cubital vein of healthy donors
and stabilised with acid citrate dextrose in the ratio of 1:9. Platelet rich plasma was
prepared by centrifugation at 200g, 20 min, room temperature (RT). Platelets were
washed twice at 1000g in the presence of 10 µg PGI2 and resuspended in
Tyrode’s–HEPES buffer (134 mM NaCl, 0.34 mM Na2HPO4, 2.9 mM KCl, 12 mM
NaHCO3, 20 mM HEPES, 5 mM glucose, 1 mM MgCl2; pH 7.3). Washed platelets
were allowed to rest for 30 min, were then labelled with calcein AM and returned to
the whole blood, which was immediately used in microfluidics experiments.
3D printing. Larger moulds were printed using a resin 3D printer (Form 2 ste-
reolithography 3D printer, Germany). The 3D printed channel mould was used to
prepare a PDMS channel following the method mentioned previously (see channel
fabrication). The valves were 3D printed separately and incorporated into the
channel, before sealing the device with a glass slide.
A 60 mL syringe was used to pump a 0.1% (w/v) 200 nm PS nanoparticle
suspension through the large device for GPV detection of the flow patterns around
the valve. A lower concentration of nanoparticles is needed to reduce the signal to
noise ratio, as well as further reduction of the aperture on the condenser lens
compared to the microfluidic model29. To increase the field of view a 10×
magnification objective and acquisition in multiple positions along the axis of the
channel was required (see Fig. 8).
Data availability
The data that support the findings of this study are available from the corresponding
author upon reasonable request.
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